Company intelligence / Profile preview
National Immunobiological Company
- Ownership
- Private
- Employees
- ~5500
- Development stage
- Other
Overview
The company manufactures over 250 medical products and is the largest manufacturer of immunobiological products in Russia. It became the sole supplier of Sputnik V coronavirus vaccine in Russia in March 2021 and produces vaccines for the National Calendar of Preventive Vaccinations.
- Therapeutic areas
- HematologyImmunologyInfectious Diseases
- Modalities
- VaccineRecombinant proteinSmall moleculeEnzyme replacement therapy
- Industry
- Pharma
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on National Immunobiological Company.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on National Immunobiological Company.